Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Drugs Dermatol ; 8(11): 1031-3, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19894372

ABSTRACT

Moxifloxacin was recently reported to induce combined features of drug hypersensitivity syndrome (DHS) and toxic epidermal necrolysis (TEN). A simultaneous presentation of these two potentially life-threatening cutaneous drug eruptions with systemic features in the same patient is considered rare since they are probably induced by two separate mechanisms. There is only one previously reported case in which moxifloxacin was implicated in the induction of these combined drug hypersensitivity processes. This article presents the case of a 44-year-old Asian male who developed features of both TEN and DHS approximately one week after initial ingestion of moxifloxacin.


Subject(s)
Aza Compounds/adverse effects , Drug Hypersensitivity/etiology , Quinolines/adverse effects , Stevens-Johnson Syndrome/etiology , Adult , Anti-Infective Agents/adverse effects , Asian People , Fluoroquinolones , Humans , Male , Moxifloxacin
3.
Surgery ; 143(5): 667-78, 2008 May.
Article in English | MEDLINE | ID: mdl-18436015

ABSTRACT

BACKGROUND: Cholestatic liver injury from extrahepatic biliary obstruction is well characterized by inflammatory and fibrogenic mechanisms. Little is known, however, about mechanisms required to reverse injury and effect liver repair. We sought to determine the cellular and molecular requirements for repair after biliary decompression, focusing on the role of hepatic macrophages in regulating inflammation and matrix resolution. METHODS: Male Sprague-Dawley rats underwent bile duct obstruction for 7 days followed by ductular decompression. Rats were treated with gadolinium chloride (GdCl(3)) to deplete the macrophage populations 24 or 48 hours before decompression. Liver tissue obtained at the time of decompression or after 2 days of repair was processed for morphometric analysis, immunohistochemistry, quantitative RT-PCR and in situ hybridization. RESULTS: GdCl(3) treatment for either 24 or 48 hours before decompression reduced the numbers of ED2(+) Kupffer cells and ED1(+) inflammatory macrophages in obstructed livers; only 48 hours of pretreatment, however, reduced the neutrophil counts. Furthermore, 48-hour GdCl(3) pretreatment blocked matrix degradation. Quantitative polymerase chain reaction demonstrated decreased cytokine-induced neutrophil chemoattractant-1 (CINC-1; CXCL1) and intercellular adhesion molecule-1 mRNA expression after GdCl(3) treatment and the elimination of hepatic macrophages. Immunohistochemistry and in situ hybridization revealed that neutrophils and CINC-1 mRNA localize within regions of fibrotic activity during both injury and repair. CONCLUSION: We conclude that the macrophage population is not directly involved in fibrotic liver repair. Rather, hepatic macrophages regulate the influx of neutrophils, which may play a direct role in matrix degradation.


Subject(s)
Cholestasis, Extrahepatic/immunology , Liver Cirrhosis/immunology , Liver Regeneration/immunology , Macrophages/physiology , Neutrophils/physiology , Animals , Chemokine CXCL1/metabolism , Cholestasis, Extrahepatic/complications , Gene Expression , Liver/immunology , Liver/metabolism , Liver Cirrhosis/etiology , Liver Cirrhosis/metabolism , Liver Regeneration/physiology , Male , Rats , Rats, Sprague-Dawley
4.
Surgery ; 138(2): 313-20, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16153442

ABSTRACT

BACKGROUND: Although timely surgical treatment of liver disease can interrupt inflammation and reduce fibrosis, the mechanisms of repair are unknown. We questioned whether these mechanisms of repair include changes in the inflammatory infiltrate and associated biological activity of matrix metalloproteinases (MMPs) 8 and 2. METHODS: Rats (n >or= 3) underwent biliary ductal suspension for 7 days followed by decompression. Livers were collected after 7 days of obstruction (d0) and after 2, 5, and 7 days of repair (d2, d5, d7, respectively), and assessed morphometrically for collagen, polymorphonuclear cells (PMNs), Kupffer cells (KCs), and inflammatory mononuclear phagocytes (MNPs). In situ zymography was performed by using fluorogenic substrates for MMP-8 and MMP-2 to spatially localize enzymatic activity. RESULTS: Cholestatic injury resulted in significantly elevated (P

Subject(s)
Cholestasis/immunology , Cholestasis/metabolism , Liver/immunology , Matrix Metalloproteinase 8/metabolism , Neutrophils/immunology , Animals , Bilirubin/blood , Cholestasis/surgery , Collagen/metabolism , Decompression, Surgical , Liver/metabolism , Liver Cirrhosis/immunology , Liver Cirrhosis/metabolism , Liver Cirrhosis/surgery , Liver Diseases/immunology , Liver Diseases/metabolism , Liver Diseases/surgery , Male , Matrix Metalloproteinase 2/metabolism , Neutrophils/enzymology , Rats , Rats, Inbred Strains
5.
Am J Pathol ; 164(4): 1471-9, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15039234

ABSTRACT

Genetic loss of surface Fas antigen expression leads to reduced apoptosis of myeloid and lymphoid progenitor cells, and a propensity to develop autoimmunity and myeloid leukemia in mouse models. Oncogenic p21(ras) decreases surface Fas antigen expression and renders fibroblasts resistant to Fas mediated apoptosis. Neurofibromin, which is encoded by NF1, is a GTPase activating protein that negatively regulates p21(ras) activity. NF1 loss leads to deregulation of p21(ras)-effector pathways, which control myeloid cell survival. Heterozygous inactivation of Nf1 increases mast cell numbers in Nf1 +/- mice, and enhances mast cell survival in response to c-kit ligand (kit-L). Here, we show that Nf1-deficient mast cells have reduced surface Fas antigen expression in response to kit-L and are resistant to Fas ligand-mediated apoptosis. Using genetic intercrosses between Nf1 +/- and class I (A)-PI-3K-deficient mice, we demonstrate that hyperactivation of the p21(ras)-class I(A) PI-3K pathway is the mechanism for this phenotype. Finally, we demonstrate that mast cells from both Fas antigen-deficient mice and Nf1 +/- mice are resistant to apoptosis following kit-L withdrawal in vivo. Thus, therapies designed to decrease p21(ras) activity and up-regulate Fas antigen expression may limit the pathological accumulation of myeloid cells in disease states where p21(ras) is hyperactivated.


Subject(s)
Genes, Neurofibromatosis 1/physiology , Mast Cells/physiology , Myeloid Cells/physiology , fas Receptor/biosynthesis , Animals , Apoptosis/physiology , Cells, Cultured , Disease Models, Animal , Flow Cytometry , Fluorescent Antibody Technique , In Situ Nick-End Labeling , Leukemia, Myeloid/genetics , Leukemia, Myeloid/immunology , Liver/cytology , Mice , Neurofibromatosis 1/genetics , Neurofibromatosis 1/immunology , Proto-Oncogene Proteins p21(ras)/metabolism , Stem Cell Factor/metabolism , Transduction, Genetic
6.
Blood ; 102(1): 142-5, 2003 Jul 01.
Article in English | MEDLINE | ID: mdl-12623844

ABSTRACT

In vitro studies suggest that activation of class IA phosphatidylinositol 3 (PI-3) kinase is necessary for normal erythroid cell development. However, when class IA PI-3 kinase-deficient mice were generated by a targeted deletion of the p85alpha regulatory subunit, fetal erythropoiesis was reportedly unaffected. Given the discrepancies between these studies, we performed a more detailed in vivo analysis of class IA PI-3 kinase-deficient embryos. Day-14.5 p85alpha-/- embryos are pale with a marked reduction of mature erythrocytes in their peripheral blood. Further, the absolute number and frequency of both early (erythroid burst-forming unit [BFU-E]) and late erythroid progenitors (erythroid colony-forming unit [CFU-E]) are reduced in p85alpha-/- fetal livers compared with wild-type controls, which is associated with reduced proliferation. Taken together, these data establish an important role for p85alpha and class IA PI-3 kinase in regulating the development of both early and late erythroid progenitors in fetal liver.


Subject(s)
Erythropoiesis/genetics , Genes/physiology , Phosphatidylinositol 3-Kinases/genetics , Animals , Apoptosis , Cell Count , Cell Division , Erythroid Precursor Cells/cytology , Fetus , Liver , Mice , Mice, Knockout , Phosphatidylinositol 3-Kinases/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...